Our Summary

This study examines the use of the Sonata® System in treating fibroids, which are common non-cancerous tumors in the uterus. The Sonata® System uses radiofrequency to destroy fibroids without needing to make any cuts or remove any organs. The team looked at the cases of 50 patients who had at least one fibroid that was 5cm or larger and were experiencing bleeding. In total, they treated 57 fibroids with this method. The smallest fibroid treated was 4cm and the largest was 12cm. The treatment time varied based on the size of the fibroid, with the shortest treatment taking just over 3 minutes and the longest taking 25 minutes. The majority of patients (86%) reported that their symptoms improved after the treatment. The researchers concluded that the Sonata® System is an effective, quick, and simple method to treat even large fibroids.

FAQs

  1. What is the Sonata® System and how is it used to treat fibroids?
  2. What was the size range of the fibroids treated in the study with the Sonata® System?
  3. How effective was the Sonata® System in treating fibroids based on the patients’ reported symptoms?

Doctor’s Tip

A doctor might tell a patient considering uterine ablation that the Sonata® System is a safe and effective option for treating fibroids. The procedure is minimally invasive, does not require any incisions, and has a quick recovery time. Patients can expect improvement in their symptoms, such as heavy menstrual bleeding, after undergoing this treatment. It is important to discuss all treatment options with your doctor to determine the best course of action for your individual situation.

Suitable For

Patients who are typically recommended uterine ablation are those who have heavy menstrual bleeding (menorrhagia) that has not responded to other treatments, such as medication or hormonal therapy. Uterine ablation may also be recommended for patients who have fibroids or polyps in the uterus that are causing symptoms such as heavy bleeding, cramping, or pelvic pain. Additionally, patients who are not able or do not want to undergo a hysterectomy may be good candidates for uterine ablation. It is important for patients to discuss their symptoms and treatment options with their healthcare provider to determine if uterine ablation is the right choice for them.

Timeline

Before uterine ablation:

  1. Patient presents with symptoms such as heavy menstrual bleeding, pelvic pain, and frequent urination.
  2. Patient undergoes diagnostic tests such as ultrasound or MRI to confirm the presence of fibroids.
  3. Patient discusses treatment options with their healthcare provider, including uterine ablation.

After uterine ablation:

  1. Patient undergoes the uterine ablation procedure using the Sonata® System.
  2. Patient may experience some mild discomfort or cramping after the procedure.
  3. In the weeks following the procedure, the patient’s symptoms gradually improve.
  4. Follow-up appointments are scheduled to monitor the patient’s progress and ensure the fibroids have been successfully treated.
  5. Patient experiences long-term relief from symptoms such as heavy menstrual bleeding and pelvic pain.

What to Ask Your Doctor

  1. What is uterine ablation and how does it work?
  2. Am I a suitable candidate for uterine ablation?
  3. What are the potential risks and complications associated with uterine ablation?
  4. What are the expected outcomes and success rates of uterine ablation for treating fibroids?
  5. How long does the procedure take and what is the recovery time?
  6. Will I need any follow-up appointments or additional treatments after the procedure?
  7. Are there any lifestyle changes or restrictions I should follow after uterine ablation?
  8. How long will the effects of uterine ablation last?
  9. What are the alternatives to uterine ablation for treating fibroids?
  10. Can you provide me with more information about the Sonata® System and its use in uterine ablation?

Reference

Authors: Piriyev E, Schiermeier S, Bends R, Römer T. Journal: J Gynecol Obstet Hum Reprod. 2022 Feb;51(2):102303. doi: 10.1016/j.jogoh.2021.102303. Epub 2021 Dec 30. PMID: 34973479